Logo image of LIVN

LIVANOVA PLC (LIVN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:LIVN - GB00BYMT0J19 - Common Stock

63.84 USD
+0.53 (+0.84%)
Last: 11/26/2025, 4:02:05 PM
63.84 USD
0 (0%)
After Hours: 11/26/2025, 4:02:05 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to LIVN. LIVN was compared to 188 industry peers in the Health Care Equipment & Supplies industry. LIVN has an average financial health and profitability rating. LIVN may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year LIVN was profitable.
In the past year LIVN had a positive cash flow from operations.
In multiple years LIVN reported negative net income over the last 5 years.
LIVN had a positive operating cash flow in 4 of the past 5 years.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

The Return On Assets of LIVN (-8.50%) is better than 63.83% of its industry peers.
LIVN has a better Return On Equity (-18.79%) than 61.70% of its industry peers.
With an excellent Return On Invested Capital value of 8.35%, LIVN belongs to the best of the industry, outperforming 85.64% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LIVN is significantly below the industry average of 8.71%.
The 3 year average ROIC (3.45%) for LIVN is below the current ROIC(8.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.5%
ROE -18.79%
ROIC 8.35%
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

With an excellent Operating Margin value of 14.95%, LIVN belongs to the best of the industry, outperforming 83.51% of the companies in the same industry.
LIVN's Operating Margin has improved in the last couple of years.
LIVN has a better Gross Margin (68.50%) than 73.94% of its industry peers.
In the last couple of years the Gross Margin of LIVN has remained more or less at the same level.
Industry RankSector Rank
OM 14.95%
PM (TTM) N/A
GM 68.5%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LIVN is destroying value.
LIVN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, LIVN has more shares outstanding
LIVN has a worse debt/assets ratio than last year.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.75, we must say that LIVN is in the distress zone and has some risk of bankruptcy.
LIVN has a Altman-Z score (1.75) which is in line with its industry peers.
LIVN has a debt to FCF ratio of 2.27. This is a good value and a sign of high solvency as LIVN would need 2.27 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.27, LIVN belongs to the top of the industry, outperforming 87.23% of the companies in the same industry.
LIVN has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of LIVN (0.30) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.27
Altman-Z 1.75
ROIC/WACC0.97
WACC8.62%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

LIVN has a Current Ratio of 1.33. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
LIVN's Current ratio of 1.33 is on the low side compared to the rest of the industry. LIVN is outperformed by 79.79% of its industry peers.
A Quick Ratio of 1.12 indicates that LIVN should not have too much problems paying its short term obligations.
LIVN's Quick ratio of 1.12 is on the low side compared to the rest of the industry. LIVN is outperformed by 74.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.12
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
The Earnings Per Share has been growing slightly by 1.82% on average over the past years.
The Revenue has grown by 8.63% in the past year. This is quite good.
Measured over the past years, LIVN shows a small growth in Revenue. The Revenue has been growing by 2.94% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%

3.2 Future

The Earnings Per Share is expected to grow by 11.46% on average over the next years. This is quite good.
LIVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.61% yearly.
EPS Next Y13.5%
EPS Next 2Y11.36%
EPS Next 3Y10.46%
EPS Next 5Y11.46%
Revenue Next Year8.58%
Revenue Next 2Y8.24%
Revenue Next 3Y7.55%
Revenue Next 5Y5.61%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.58 indicates a correct valuation of LIVN.
Based on the Price/Earnings ratio, LIVN is valued cheaper than 85.64% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.98. LIVN is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 15.28 indicates a correct valuation of LIVN.
86.17% of the companies in the same industry are more expensive than LIVN, based on the Price/Forward Earnings ratio.
LIVN is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.58
Fwd PE 15.28
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LIVN is valued cheaper than 85.11% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LIVN is valued cheaper than 90.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.21
EV/EBITDA 13.17
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

LIVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LIVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.23
PEG (5Y)9.13
EPS Next 2Y11.36%
EPS Next 3Y10.46%

0

5. Dividend

5.1 Amount

No dividends for LIVN!.
Industry RankSector Rank
Dividend Yield N/A

LIVANOVA PLC

NASDAQ:LIVN (11/26/2025, 4:02:05 PM)

After market: 63.84 0 (0%)

63.84

+0.53 (+0.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners103.79%
Inst Owner Change2.38%
Ins Owners0.28%
Ins Owner Change3.57%
Market Cap3.49B
Revenue(TTM)1.35B
Net Income(TTM)-217.49M
Analysts82.5
Price Target68.98 (8.05%)
Short Float %3.36%
Short Ratio3.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.36%
Min EPS beat(2)18.42%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)12.75%
Min EPS beat(4)-0.89%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)18.55%
EPS beat(12)11
Avg EPS beat(12)18.19%
EPS beat(16)14
Avg EPS beat(16)14.3%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.79%
Revenue beat(12)11
Avg Revenue beat(12)3.51%
Revenue beat(16)13
Avg Revenue beat(16)2.69%
PT rev (1m)6.29%
PT rev (3m)6.29%
EPS NQ rev (1m)-10.19%
EPS NQ rev (3m)-9.99%
EPS NY rev (1m)0%
EPS NY rev (3m)0.06%
Revenue NQ rev (1m)-0.96%
Revenue NQ rev (3m)-1.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.08%
Valuation
Industry RankSector Rank
PE 16.58
Fwd PE 15.28
P/S 2.58
P/FCF 18.21
P/OCF 13.91
P/B 3.01
P/tB 26.47
EV/EBITDA 13.17
EPS(TTM)3.85
EY6.03%
EPS(NY)4.18
Fwd EY6.55%
FCF(TTM)3.51
FCFY5.49%
OCF(TTM)4.59
OCFY7.19%
SpS24.71
BVpS21.19
TBVpS2.41
PEG (NY)1.23
PEG (5Y)9.13
Graham Number42.85
Profitability
Industry RankSector Rank
ROA -8.5%
ROE -18.79%
ROCE 11.65%
ROIC 8.35%
ROICexc 13.32%
ROICexgc 247.47%
OM 14.95%
PM (TTM) N/A
GM 68.5%
FCFM 14.19%
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.42%
ROICexc growth 3Y38.42%
ROICexc growth 5Y24.6%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.27
Debt/EBITDA 1.42
Cap/Depr 132%
Cap/Sales 4.39%
Interest Coverage 250
Cash Conversion 101.69%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.12
Altman-Z 1.75
F-Score6
WACC8.62%
ROIC/WACC0.97
Cap/Depr(3y)78.91%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
EPS Next Y13.5%
EPS Next 2Y11.36%
EPS Next 3Y10.46%
EPS Next 5Y11.46%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
Revenue Next Year8.58%
Revenue Next 2Y8.24%
Revenue Next 3Y7.55%
Revenue Next 5Y5.61%
EBIT growth 1Y51.21%
EBIT growth 3Y51.09%
EBIT growth 5Y22.46%
EBIT Next Year34.28%
EBIT Next 3Y14.67%
EBIT Next 5Y3.21%
FCF growth 1Y2161.93%
FCF growth 3Y20.82%
FCF growth 5YN/A
OCF growth 1Y532.01%
OCF growth 3Y21.3%
OCF growth 5YN/A

LIVANOVA PLC / LIVN FAQ

Can you provide the ChartMill fundamental rating for LIVANOVA PLC?

ChartMill assigns a fundamental rating of 5 / 10 to LIVN.


What is the valuation status for LIVN stock?

ChartMill assigns a valuation rating of 7 / 10 to LIVANOVA PLC (LIVN). This can be considered as Undervalued.


How profitable is LIVANOVA PLC (LIVN) stock?

LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.


What is the valuation of LIVANOVA PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for LIVANOVA PLC (LIVN) is 16.58 and the Price/Book (PB) ratio is 3.01.


How financially healthy is LIVANOVA PLC?

The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.